BioNTech raises $250 million from investors including Temasek

BioNTech (BNTX.O) said Singapore’s state investment company Temasek and other investors are injecting $250 million into the German biotech firm through a private placement.

The company, which is developing a COVID-19 vaccine, said the transaction includes the purchase of about $139 million in ordinary shares and a $112 million investment in 4-year mandatory convertible notes.

https://www.reuters.com/article/us-biontech-placement/biontech-raises-250-million-from-investors-including-temasek-idUSKBN2400PS